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ABSTRACT
Background and aim: There is a high prevalence in the Spanish general population of some cardiovascular 
risk factors like overweight, obesity and hypercholesterolaemia. But there is lack of research on Spanish 
seafarers. On the other hand, there is strong evidence of the cardiovascular risk predictive value of some 
biomarkers. The purpose of this work was to study the convenience of the introduction of detailed diet 
questionnaires and the measurement of some biomarkers in the pre-embarkation medical examination.
Materials and methods: Seafarers undergoing medical checkup during 2011 in Madrid, Spain (n = 334). 
Overweight and obese subjects received general advice on healthy diet and physical activity. Seventy-four of 
them were followed up in 2012 and 2013. Glycated haemoglobin (HbA1c), high-sensitivity C-reactive protein 
(hs-CRP), thyrotropin (TSH) and microalbuminuria were measured in two selected groups of patients in 2011.
Results: Overweight and obesity were present in 207 (62%) individuals of the studied population. Those 
followed up in 2012 and 2013 showed a reduction of body mass index, waist circumference and total 
cholesterol values. We observed risk value of HbA1c in 60 (35.5%) individuals with significant association 
to other cardiovascular risk factors. Microalbuminuria appeared in subjects with high blood pressure. High 
TSH and hs-CRP were not significantly present in our population. 
Conclusions: 1. Measurement of HbA1c during medical checkups improves early detection of cardiovascular 
risk in seafarers. 2. Individuals with overweight and obesity responded positively to medical advice and 
diminished their risk factors, thus it may be more effective to introduce detailed questionnaires on this issue. 
(Int Marit Health 2016; 67, 1: 3–8)
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INTRODUCTION
Several works have been carried out in the last decades, 
showing the high prevalence of some cardiovascular risk 
factors among the Spanish general population: high blood 
pressure and hypercholesterolaemia (> 40%); obesity and 
smoke habit (> 27%); and diabetes mellitus (> 13%) [1].
However, there is a lack of research on Spanish seafar-
ers (nearly 70,000 workers nowadays), which usually work 
under hard conditions that need a particular administrative 
and sanitary regulation.
The last report of the Spanish Occupational Safety 
and Hygiene National Institute (2013) emphasizes the 
higher risks of working on board compared with other 
labour areas, including fourfold myocardial infarction and 
stroke risk. 
Working seamen often spend long periods of time em-
barked and do not frequently visit physicians ashore. It is 
also very difficult to follow up the compliance of treatment 
due to the particular labour conditions on board, long pe-
riods offshore and wide geographical dispersion of these 
workers.
Usually, their sole contact with a physician is the pre-em-
barkation medical examination, which constitutes the best 
chance to detect and prevent any health problem. Accord-
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ing to Tim Carter: “The main approach to risk reduction (of 
accidents on board) is by the application of fitness criteria to 
seafarers during medical examinations” [2]. 
Pre-embarkation medical checkup’s objective is to deter-
mine if seafarers’ physical and psychological conditions are 
adequate to their work on board, with no risk for their own 
health, other crewmembers’ or passengers’ safety, according 
to Spanish Law (Real Decreto 1696/2007). 
Seamen are obliged to undergo pre-embarkation checkup 
every 2 years, in ages from 21 to 50, and every year if younger 
than 21 or older than 50. 
On the other hand, it is well known that the course of the 
atherosclerosis disease is silent during long periods of time; 
so acute ischaemic events take place often in apparently 
healthy people [3], which must be evaluated carefully.
Several studies have shown the predictive value of various 
biomarkers in the development of cardiovascular disease. We de-
cided to include in this work the measurement of following param-
eters in a selected group: glycated haemoglobin (HbA1c) [4–7], 
high-sensitivity C-reactive protein (hs-CRP) [8–10], thyrotropin 
(TSH) [11–14], microalbuminuria [15–17], especially for their 
good cost–efficiency and easy accessibility.
The aim of the study was: 1) To establish if the intro-
duction of more detailed dietary questionnaire and medical 
advice during pre-embarkation examinations would obtain 
better results in diminishing overweight and obesity among 
seafarers. 2) To determine if the measurement of some 
cardiovascular risk biomarkers means an improvement in 
the early detection of cardiovascular risk in seafarers during 
pre-embarkation medical checkups.
MATERIALS AND METHODS
During 2011, 334 patients went under pre-embarka-
tion medical exam in the Maritime Health Service of Ma-
drid, Spain, including anamnesis, physical examination and 
the measurement of some parameters established by our 
protocols, like glucose blood levels, total cholesterol, high 
density lipoprotein (HDL)-cholesterol, low density lipoprotein 
(LDL)-cholesterol and triglycerides.
During the pre-embarkation medical examinations, we ob-
served a high prevalence of overweight and obesity among our 
population. Thus, we gave them general advice on healthy diet 
and physical activity to help them to lose weight and we decid-
ed to follow up these individuals in the next medical checkup 
(1 or 2 years later depending on their age). The recommenda-
tions consisted of reducing fat and carbohydrates intake and 
practicing aerobic physical activity for 20–30 min every day.
On the other hand, two groups of individuals were select-
ed to measure HbA1c, hs-CRP, TSH and microalbuminuria 
in them. 
The inclusion criteria in the first group were: 
 — Seafarer undergoing pre-embarkation medical checkup.
 — Age between 50 (mean age for Spanish general popula-
tion’s studies consulted on cardiovascular risk) and 66 
years (upper limit of age in our population). 
The inclusion criteria in the second group:
 — Seafarer undergoing pre-embarkation medical checkup.
 — Age between 18 and 49 years with high blood pressure 
or hyperglycaemia or dyslipidaemia or obesity; also if 
having relatives with premature cardiovascular disease 
or diabetes mellitus.
The exclusion criteria for both groups were:
 — Having suffered a cardiovascular event in the last 5 years.
 — Presence of infectious or inflammatory illness at the 
moment of medical checkup.
Glycated haemoglobin was measured using the HPLC-Cal-
ibration NGSP (DCCT) technique. Its values are expressed in 
percentage. Cutoff point considered as cardiovascular risk 
predictive was ≥ 5.7%.
High-sensitivity C-reactive protein was determined by 
immunoturbidimetry. It is expressed in mg/dL. Its normal 
value is 0.500 mg/dL.
Thyrotropin was measured using chemiluminescence 
system and expressed as μUI/mL. Normal values are from 
0.550 to 4.780 μUI/mL. It is used as predictive cardiovas-
cular risk biomarker when its value is under 0.10 mUI/L and 
over 10 mUI/L.
Microalbuminuria was also measured by immunoturbidi-
metry. It is expressed in mg/L. Normal value is < 30 mg/L. Its 
value as predictive cardiovascular risk biomarker is between 
30 and 300 mg per day.
STATISTICAL ANALySES
We studied the distribution of risk factors in our popu-
lation and the possibility of statistical association amongst 
themselves. Quantitative variables were encoded and cate-
gorised following risk criteria. Chi-square test, Fisher’s exact 
test (for relations between categorical variables) and odds 
ratio (OR) were used.
Some variables were dichotomised and we looked up for 
association with others, analysing OR, obtained by logistic 
binary regression. To determine the association among 
quantitative variables, lineal regression and correlation 
tests were utilised.
To carry out this study, we used the SSPS Statistics 21 
Program.
RESULTS 
MAIN PARAMETERS IN THE POPULATION  
ExAMINED IN 2011
The population examined during 2011 (n = 334) was 
mainly male (86.2% men, 13.8% women) and young (44.9% 
older than 45 years; age range 23–66 years, mean 47.13 
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Table 1. Main variables observed in the population examined 
in 2011 (n = 334)
Variable Classification N %
Sex Men 288 86.2
Women 46 13.8
Age < 45 years 184 55.1
≥ 45 years 150 44.9
Blood pressure No risk 200 59.9
Risk 134 40.1
Blood cholesterol No risk 168 50.3
Risk 166 49.7
Tobacco use Non smoker 222 66.5
Smoker 112 33.5
Weight Normal 127 38
Overweight 149 44.6
Obesity 58 17.4
Waist circumference No risk 244 73.1
Risk 84 25.1
Metabolic syndrome Absent 285 85.3
Present 48 14.4
Table 2. Evolution of followed-up population (n = 74)
Parameter Mean baseline values
(in 2011)
Mean values after 
medical advice
(in 2012–2013)
P Improvement
(= reduction) 
in 2012–2013
No improvement
(= no reduction)
in 2012–2013
N % N %
Body mass index Men: 30.9 29.26 > 0.05 28 40.6 41 59.4
Women: 30.7 30.8 > 0.05 3 60 2 40
Total 29.2 29.37 > 0.05 31 41.9 43 58.1
Waist circumfe-
rence [cm]*
Men: 102.57 100.37 < 0.05 43 62,3 26 37.68
Women: 90.8 88.8 > 0.05 3 60 2 40
Total 101.8 99.6 < 0.05 46 62,2 28 37.8
Blood cholesterol 
[md/dL]
Men: 219.8 211.7 < 0.05 37 53.6 32 46.4
Women: 223.8 194.8 > 0.05 1 20 4 80
Total 214.4 208.1 > 0.05 38 51,4 36 48.6
*Waist circumference risk values are different for men (≥ 102 cm) and women (≥ 88 cm). The table expresses the means of the measured values before and after the in-
tervention and the percentage of the reduction, considered as improvement, of these parameters: body mass index, waist circumference and blood total cholesterol level, 
in those subjects re-examined in 2012 or 2013 (depending on age medical checkup must be renewed every year for older than 50 years and every two years for younger 
seafarers), 74 of the subjects being overweight or obese in 2011 (69 men and 5 women).
years). The most prevalent cardiovascular risk factors in 
our population were: high blood pressure (40.1%), hyper-
cholesterolaemia (49.7%), tobacco use (33.5%), overweight 
(44.6%) and obesity (17.4%) (Table 1).
FOLLOw-UP OF THE SUBGROUP
We managed to re-examine (in 2012 or 2013) 74 of 
the 207 subjects who presented overweight and obesity in 
2011. All of them had received general medical advice on 
proper dietary and physical activity habits. 
In the new medical checkup, we observed that:
 — 31 (41.9%) patients reduced their body mass index (BMI) 
(28 men, 3 women);
 — 46 (62.2%) subjects reduced their abdominal waist 
circumference (43 men, 3 women).
 — 37 (50%), showed lower values of total cholesterol 
(37 men, 1 woman).
The reduction of waist circumference and blood cho-
lesterol was significant in men, but not in women (Table 2).
wITH REGARD TO PREDICTIVE BIOMARKERS
Glycated haemoglobin was measured in 172 patients 
and was ≥ 5.7% in 61 of them (35.5%). No significance 
distribution among sexes was found (Table 3). 
When considering each subgroup of selected patients 
separately, we found a higher prevalence of HbA1c ≥ 5.7% 
in the group of subjects older than 50, with no significant 
difference though (Table 4).
Risk values of HbA1c were significantly more prevalent 
among patients with glucose blood levels ≥ 100 mg/dL 
(p < 0.01) and among subjects with metabolic syndrome 
(p < 0.01). Metabolic syndrome is defined as the pres-
ence of at least three of following criteria: 1) Waist cir-
cumference ≥ 102 cm in men and 88 cm in women; 
2) Triglycerides ≥ 150 mg/dL (or under treatment). 
3) HDL-cholesterol < 40 mg/dL in men and < 50 mg/dL 
in women (or under treatment); 4) Blood pressure 
≥ 130/85 mm Hg (or under treatment); 5) Glucose blood 
level ≥ 100 mg/dL (or under treatment).
In relation to BMI, HbA1c was more prevalent among 
overweight and obese patients (World Health Organisation 
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Table 3. Biomarkers’ distribution among sexes
Biomarker Men women
N Risk % N Risk % P
HbA1c 159 58 36.5 13 3 23.1 > 0.05
hs-CRP 154 17 11.25 13 2 15.38 > 0.05
TSH 157 8 5.1 13 0 0 > 0.05
Microalbuminuria 154 8 5.19 13 1 7.69 > 0.05
HbA1c — glycated haemoglobin, hs-CRP — high-sensitivity C-reactive protein; TSH — thyrotropin; N — total number of individuals included; Risk — number of subjects with 
risk levels of biomarker; % — percentage of subjects with biomarkers’ risk levels; p — statistical significance
Table 4. Biomarkers’ risk values in both subgroups
Biomarker Patients ≥ 50 years Patients 18–49 years (and risk factors)
N Risk % N Risk % P
HbA1c 118 47 39.8 54 14 25.9 > 0.05
hs-CRP 114 14 12.3 53 5 9.4 > 0.05
TSH 117 7 6 53 1 1.9 > 0.05
Microalbuminuria 114 8 7 53 1 1.9 > 0.05
Abbreviations as in Table 3
[WHO] establishes that: Overweight is the value of BMI 
25–29.9; obesity is BMI ≥ 30), yet not significantly (p > 
0.05). Finally, in our selected population, most patients 
had normal values of waist circumference, but we found 
that high HbA1c was more prevalent among those with risk 
values of waist perimeter (p < 0.05) (Fig. 1).
On the other hand, microalbuminuria was measured in 
167 and was positive in 9 patients, showing a significant 
prevalence among individuals with high blood pressure 
(p < 0.05) compared with subjects with normal blood pressure.
No significant association was observed between TSH 
(measured in 170 individuals, risk value in 8) nor hs-CRP 
(measured in 167 subjects, high value in 19) and other 
parameter’s risk values.
DISCUSSION
The prevalence of overweight and obesity in our pop-
ulation was lower than in the general Spanish population, 
according to the values given by the WHO (62% overweight 
and 26.6% obesity) [18], and was also lower than other 
countries’ seafarers (Hansen et al. [19] observed in 2010 
that 70.5% of Danish seamen, all males, showed overweight 
or obesity, while Nas and Fışkın [20] found overweight or 
obesity in 52.1% of Turkish, males too, seafarers). 
It is very interesting to notice the importance of the 
measurement of the abdominal perimeter in our protocol, 
since these workers often show a high BMI but not obesity, 
because of their great burliness. Undoubtedly, this param-
eter adds much quality to the checkups.
The reduction of the abdominal waist circumference and 
total cholesterol values in those individuals that we could 
follow up after they had received general medical advice 
on healthy habits was significant in men (we could only 
follow up 5 women, which is a very small sample). Possibly 
the medical advice given in 2011 exerted a positive effect.
However, the anamnesis referred to seamen diet in 
our electronic files program only admits “balanced” or “un-
balanced”, expressed by the patient. So, we think it could 
be recommendable to introduce a more detailed question-
naire on dietary habits in order to assess more precisely its 
correctness and to give adequate medical advice. Further 
research will be needed to determine its efficiency in the 
prevention and control of overweight, obesity and hyper-
cholesterolaemia.
Related to biomarkers, the prevalence of HbA1c risk 
values in our patients was similar to that observed in other 
populations, which is very alarming since diabetes mellitus 
is considered as a non fitness criterion for working on ships 
in Spanish Law. So, it is very important to detect these levels 
of HbA1c as early as possible.
It is necessary to emphasize that glucose blood levels 
were within normal values (< 100 mg/dL) in 37 of the 
60 individuals with HbA1c risk values included in this work, 
as occurred in other studies [7]. If we had not measured it, 
this risk situation would not have been detected. 
It was also interesting that the association were found in 
our population between HbA1c risk values and the presence 
of other cardiovascular risk factors: high glucose blood levels, 
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Figure 1. Association between glycated haemoglobin (HbA1c) and other parameters. Measured in 172 individuals
overweight/obesity, high waist circumference and metabolic 
syndrome; as found in other scientific publications [21–24].
Considering HbA1c efficiency as a predictive cardiovascular 
disease marker, our findings and its good cost–effectiveness, 
it seems convenient to include its measurement in patients 
older than 50 and in younger patients with medium or high 
cardiovascular risk during pre-embarkation medical exams. 
ETHICAL CONSIDERATIONS
We asked each individual for agreement to be part of 
this study, expressed by informed consent, according to the 
Spanish regulation currently in force. 
The Instituto Social de la Marina also gave permission 
for the management of patients’ data, under all guarantees 
established by valid Spanish laws.
LIMITATIONS AND CHALLENGES OF THIS STUDy
Since there is lack of research on seafarers’ health, 
particularly in Spain, our study adds important information. 
Our findings may lead to improve pre-embarkation medi-
cal checkups quality, as far as we introduce new biomarkers 
and questionnaires in our current protocols.
On the other hand, this study may have some bias due 
to the small size of the sample, the disproportion between 
sexes and the fact that all cases come from a unique Mar-
itime Health Service.
Further investigation on seamen’s health is needed 
using bigger samples and including subjects undergoing 
pre-embarkation medical examination in different Maritime 
Health Centres.
CONCLUSIONS
1. Since general medical advice on diet and physical activi-
ty showed a positive effect on the overweight and obese 
patients, the introduction of detailed questionnaires on 
dietary habits in our medical protocols for pre-embarka-
tion checkups may result in a great benefit for seafarers’ 
cardiovascular health.
2. The measurement of HbA1c in the pre-embarkation 
medical exam in patients over 50 years or under that 
age with personal or familial cardiovascular risk back-
ground, may be useful in early diagnose of diabetes 
mellitus and as predictive marker of cardiovascular 
disease if ≥ 5.7%.
3. The inclusion of both in our protocols will improve 
pre-embarkation medical exams quality and conse-
quently, seafarers’ health and wellbeing.
4. It should be also recommendable to obtain more impli-
cation of all concerned to get better labour conditions 
on board, particularly those related to balanced diet and 
physical activity during embarkation periods.
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